| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.32 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |